J ETHNOPHARMACOL 润色咨询

JOURNAL OF ETHNOPHARMACOLOGY

出版年份：1979 年文章数：10328 投稿命中率： 开通期刊会员，数据随心看

出版周期：Semimonthly 自引率：8.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2146523, encodeId=4e192146523e2, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：中药复方机制<br>经验分享：4.1第一次投稿，被编辑部退回，理由如下：1. 杂志一般不接受单剂量研究，如果有前期剂量筛选的话要补充依据；2. 补充受试药物的传统应用依据；3. 补充动物伦理证明。起初以为杂志不接受单剂量，转战phytomedicine （编辑建议转投）和frontiers in pharmacology（要求进行语言润色，主动撤稿）。后面经邮件咨询编辑部后，于4.30再次投稿，5.8送外审，6.27审稿意见返回，两个审稿人9个问题，编辑给了7天修改，7.3修回（9个问题回复了9页纸），7.5accept。总体感觉相对不难，但是要注意细节，例如：摘要个格式要严格按照要求来；要有动物伦理证明；如果是单剂量研究要说明理由（正文材料方法中、cover letter都要讲清楚，不然会被退稿）；中药/复方要有传统应用的依据（这里要引用相应的文献支撑）。另外，对于审稿人的刁难，舔就完事了哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jul 05 21:59:09 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162744, encodeId=86b12162e449f, content=请问各位大神，An annotated Table of Contents (Index) must be provided for reviews as required for the journal.是什么意思，要提供什么材料吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Oct 14 11:29:12 CST 2023, time=2023-10-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158170, encodeId=f0ab21581e069, content=偏重的研究方向：药理学;天然药物;药理<br>经验分享：家人们，想问一下投的综述一般要多久送审呀，投了有几天了还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Sun Sep 17 18:24:08 CST 2023, time=2023-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156372, encodeId=dce321563e2be, content=一审：第一个审稿人提了对内容提了7个问题，第二个审稿人给了接收，请问小修回去还需要送外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3008394011, createdName=ms3000000237799877, createdTime=Wed Sep 06 14:15:05 CST 2023, time=2023-09-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2181831, encodeId=490a2181831d7, content=投稿要求“Please download a paper from the journal website and use it as an example to correct the format of your paper.”请问文章格式是什么啊，怎么改啊，急求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff78834013, createdName=ms9000000742155435, createdTime=Mon Jan 15 17:47:34 CST 2024, time=2024-01-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147022, encodeId=0f71214e02205, content=投稿一周了还是submited to journal, 真的很希望送审。我是筛药的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aa96399896, createdName=ms1000000125278461, createdTime=Sat Jul 08 22:12:51 CST 2023, time=2023-07-08, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170852, encodeId=be0d21e085259, content=请问online之后多久能拿到检索证明啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6d5433134, createdName=ms3000001423208311, createdTime=Sat Nov 25 08:16:05 CST 2023, time=2023-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176059, encodeId=c7ae21e6059ed, content=5天了，还是Submitted to Journal，要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Wed Dec 20 10:30:53 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175358, encodeId=411221e5358f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：中药复方<br>经验分享：各位老师，我看投稿要求里说要文章总体介绍的图片，这个大家有上传吗，还是不用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=ms2000000165165359, createdTime=Sun Dec 17 01:54:50 CST 2023, time=2023-12-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2167310, encodeId=0faf216e3103c, content=请问中药抑菌的文章适不适合投呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f48d9034239, createdName=ms1000001299592747, createdTime=Wed Nov 08 00:36:49 CST 2023, time=2023-11-08, status=1, ipAttribution=广西)]
    2023-07-05 卡球球 zhao 来自广东省

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向：中药复方机制
    经验分享：4.1第一次投稿，被编辑部退回，理由如下：1. 杂志一般不接受单剂量研究，如果有前期剂量筛选的话要补充依据；2. 补充受试药物的传统应用依据；3. 补充动物伦理证明。起初以为杂志不接受单剂量，转战phytomedicine （编辑建议转投）和frontiers in pharmacology（要求进行语言润色，主动撤稿）。后面经邮件咨询编辑部后，于4.30再次投稿，5.8送外审，6.27审稿意见返回，两个审稿人9个问题，编辑给了7天修改，7.3修回（9个问题回复了9页纸），7.5accept。总体感觉相对不难，但是要注意细节，例如：摘要个格式要严格按照要求来；要有动物伦理证明；如果是单剂量研究要说明理由（正文材料方法中、cover letter都要讲清楚，不然会被退稿）；中药/复方要有传统应用的依据（这里要引用相应的文献支撑）。另外，对于审稿人的刁难，舔就完事了哈哈哈！

    20

    展开20条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2146523, encodeId=4e192146523e2, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：中药复方机制<br>经验分享：4.1第一次投稿，被编辑部退回，理由如下：1. 杂志一般不接受单剂量研究，如果有前期剂量筛选的话要补充依据；2. 补充受试药物的传统应用依据；3. 补充动物伦理证明。起初以为杂志不接受单剂量，转战phytomedicine （编辑建议转投）和frontiers in pharmacology（要求进行语言润色，主动撤稿）。后面经邮件咨询编辑部后，于4.30再次投稿，5.8送外审，6.27审稿意见返回，两个审稿人9个问题，编辑给了7天修改，7.3修回（9个问题回复了9页纸），7.5accept。总体感觉相对不难，但是要注意细节，例如：摘要个格式要严格按照要求来；要有动物伦理证明；如果是单剂量研究要说明理由（正文材料方法中、cover letter都要讲清楚，不然会被退稿）；中药/复方要有传统应用的依据（这里要引用相应的文献支撑）。另外，对于审稿人的刁难，舔就完事了哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jul 05 21:59:09 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162744, encodeId=86b12162e449f, content=请问各位大神，An annotated Table of Contents (Index) must be provided for reviews as required for the journal.是什么意思，要提供什么材料吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Oct 14 11:29:12 CST 2023, time=2023-10-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158170, encodeId=f0ab21581e069, content=偏重的研究方向：药理学;天然药物;药理<br>经验分享：家人们，想问一下投的综述一般要多久送审呀，投了有几天了还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Sun Sep 17 18:24:08 CST 2023, time=2023-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156372, encodeId=dce321563e2be, content=一审：第一个审稿人提了对内容提了7个问题，第二个审稿人给了接收，请问小修回去还需要送外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3008394011, createdName=ms3000000237799877, createdTime=Wed Sep 06 14:15:05 CST 2023, time=2023-09-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2181831, encodeId=490a2181831d7, content=投稿要求“Please download a paper from the journal website and use it as an example to correct the format of your paper.”请问文章格式是什么啊，怎么改啊，急求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff78834013, createdName=ms9000000742155435, createdTime=Mon Jan 15 17:47:34 CST 2024, time=2024-01-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147022, encodeId=0f71214e02205, content=投稿一周了还是submited to journal, 真的很希望送审。我是筛药的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aa96399896, createdName=ms1000000125278461, createdTime=Sat Jul 08 22:12:51 CST 2023, time=2023-07-08, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170852, encodeId=be0d21e085259, content=请问online之后多久能拿到检索证明啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6d5433134, createdName=ms3000001423208311, createdTime=Sat Nov 25 08:16:05 CST 2023, time=2023-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176059, encodeId=c7ae21e6059ed, content=5天了，还是Submitted to Journal，要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Wed Dec 20 10:30:53 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175358, encodeId=411221e5358f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：中药复方<br>经验分享：各位老师，我看投稿要求里说要文章总体介绍的图片，这个大家有上传吗，还是不用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=ms2000000165165359, createdTime=Sun Dec 17 01:54:50 CST 2023, time=2023-12-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2167310, encodeId=0faf216e3103c, content=请问中药抑菌的文章适不适合投呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f48d9034239, createdName=ms1000001299592747, createdTime=Wed Nov 08 00:36:49 CST 2023, time=2023-11-08, status=1, ipAttribution=广西)]
    2023-10-14 ms4000001105476217 来自北京

    请问各位大神，An annotated Table of Contents (Index) must be provided for reviews as required for the journal.是什么意思，要提供什么材料吗

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2146523, encodeId=4e192146523e2, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：中药复方机制<br>经验分享：4.1第一次投稿，被编辑部退回，理由如下：1. 杂志一般不接受单剂量研究，如果有前期剂量筛选的话要补充依据；2. 补充受试药物的传统应用依据；3. 补充动物伦理证明。起初以为杂志不接受单剂量，转战phytomedicine （编辑建议转投）和frontiers in pharmacology（要求进行语言润色，主动撤稿）。后面经邮件咨询编辑部后，于4.30再次投稿，5.8送外审，6.27审稿意见返回，两个审稿人9个问题，编辑给了7天修改，7.3修回（9个问题回复了9页纸），7.5accept。总体感觉相对不难，但是要注意细节，例如：摘要个格式要严格按照要求来；要有动物伦理证明；如果是单剂量研究要说明理由（正文材料方法中、cover letter都要讲清楚，不然会被退稿）；中药/复方要有传统应用的依据（这里要引用相应的文献支撑）。另外，对于审稿人的刁难，舔就完事了哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jul 05 21:59:09 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162744, encodeId=86b12162e449f, content=请问各位大神，An annotated Table of Contents (Index) must be provided for reviews as required for the journal.是什么意思，要提供什么材料吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Oct 14 11:29:12 CST 2023, time=2023-10-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158170, encodeId=f0ab21581e069, content=偏重的研究方向：药理学;天然药物;药理<br>经验分享：家人们，想问一下投的综述一般要多久送审呀，投了有几天了还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Sun Sep 17 18:24:08 CST 2023, time=2023-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156372, encodeId=dce321563e2be, content=一审：第一个审稿人提了对内容提了7个问题，第二个审稿人给了接收，请问小修回去还需要送外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3008394011, createdName=ms3000000237799877, createdTime=Wed Sep 06 14:15:05 CST 2023, time=2023-09-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2181831, encodeId=490a2181831d7, content=投稿要求“Please download a paper from the journal website and use it as an example to correct the format of your paper.”请问文章格式是什么啊，怎么改啊，急求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff78834013, createdName=ms9000000742155435, createdTime=Mon Jan 15 17:47:34 CST 2024, time=2024-01-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147022, encodeId=0f71214e02205, content=投稿一周了还是submited to journal, 真的很希望送审。我是筛药的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aa96399896, createdName=ms1000000125278461, createdTime=Sat Jul 08 22:12:51 CST 2023, time=2023-07-08, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170852, encodeId=be0d21e085259, content=请问online之后多久能拿到检索证明啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6d5433134, createdName=ms3000001423208311, createdTime=Sat Nov 25 08:16:05 CST 2023, time=2023-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176059, encodeId=c7ae21e6059ed, content=5天了，还是Submitted to Journal，要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Wed Dec 20 10:30:53 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175358, encodeId=411221e5358f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：中药复方<br>经验分享：各位老师，我看投稿要求里说要文章总体介绍的图片，这个大家有上传吗，还是不用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=ms2000000165165359, createdTime=Sun Dec 17 01:54:50 CST 2023, time=2023-12-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2167310, encodeId=0faf216e3103c, content=请问中药抑菌的文章适不适合投呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f48d9034239, createdName=ms1000001299592747, createdTime=Wed Nov 08 00:36:49 CST 2023, time=2023-11-08, status=1, ipAttribution=广西)]
    2023-09-17 ms6000000645412256

    偏重的研究方向：药理学;天然药物;药理
    经验分享：家人们，想问一下投的综述一般要多久送审呀，投了有几天了还没有消息。

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2146523, encodeId=4e192146523e2, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：中药复方机制<br>经验分享：4.1第一次投稿，被编辑部退回，理由如下：1. 杂志一般不接受单剂量研究，如果有前期剂量筛选的话要补充依据；2. 补充受试药物的传统应用依据；3. 补充动物伦理证明。起初以为杂志不接受单剂量，转战phytomedicine （编辑建议转投）和frontiers in pharmacology（要求进行语言润色，主动撤稿）。后面经邮件咨询编辑部后，于4.30再次投稿，5.8送外审，6.27审稿意见返回，两个审稿人9个问题，编辑给了7天修改，7.3修回（9个问题回复了9页纸），7.5accept。总体感觉相对不难，但是要注意细节，例如：摘要个格式要严格按照要求来；要有动物伦理证明；如果是单剂量研究要说明理由（正文材料方法中、cover letter都要讲清楚，不然会被退稿）；中药/复方要有传统应用的依据（这里要引用相应的文献支撑）。另外，对于审稿人的刁难，舔就完事了哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jul 05 21:59:09 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162744, encodeId=86b12162e449f, content=请问各位大神，An annotated Table of Contents (Index) must be provided for reviews as required for the journal.是什么意思，要提供什么材料吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Oct 14 11:29:12 CST 2023, time=2023-10-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158170, encodeId=f0ab21581e069, content=偏重的研究方向：药理学;天然药物;药理<br>经验分享：家人们，想问一下投的综述一般要多久送审呀，投了有几天了还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Sun Sep 17 18:24:08 CST 2023, time=2023-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156372, encodeId=dce321563e2be, content=一审：第一个审稿人提了对内容提了7个问题，第二个审稿人给了接收，请问小修回去还需要送外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3008394011, createdName=ms3000000237799877, createdTime=Wed Sep 06 14:15:05 CST 2023, time=2023-09-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2181831, encodeId=490a2181831d7, content=投稿要求“Please download a paper from the journal website and use it as an example to correct the format of your paper.”请问文章格式是什么啊，怎么改啊，急求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff78834013, createdName=ms9000000742155435, createdTime=Mon Jan 15 17:47:34 CST 2024, time=2024-01-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147022, encodeId=0f71214e02205, content=投稿一周了还是submited to journal, 真的很希望送审。我是筛药的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aa96399896, createdName=ms1000000125278461, createdTime=Sat Jul 08 22:12:51 CST 2023, time=2023-07-08, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170852, encodeId=be0d21e085259, content=请问online之后多久能拿到检索证明啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6d5433134, createdName=ms3000001423208311, createdTime=Sat Nov 25 08:16:05 CST 2023, time=2023-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176059, encodeId=c7ae21e6059ed, content=5天了，还是Submitted to Journal，要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Wed Dec 20 10:30:53 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175358, encodeId=411221e5358f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：中药复方<br>经验分享：各位老师，我看投稿要求里说要文章总体介绍的图片，这个大家有上传吗，还是不用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=ms2000000165165359, createdTime=Sun Dec 17 01:54:50 CST 2023, time=2023-12-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2167310, encodeId=0faf216e3103c, content=请问中药抑菌的文章适不适合投呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f48d9034239, createdName=ms1000001299592747, createdTime=Wed Nov 08 00:36:49 CST 2023, time=2023-11-08, status=1, ipAttribution=广西)]
    2023-09-06 ms3000000237799877 来自四川省

    一审：第一个审稿人提了对内容提了7个问题，第二个审稿人给了接收，请问小修回去还需要送外审吗

    7

    展开7条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2146523, encodeId=4e192146523e2, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：中药复方机制<br>经验分享：4.1第一次投稿，被编辑部退回，理由如下：1. 杂志一般不接受单剂量研究，如果有前期剂量筛选的话要补充依据；2. 补充受试药物的传统应用依据；3. 补充动物伦理证明。起初以为杂志不接受单剂量，转战phytomedicine （编辑建议转投）和frontiers in pharmacology（要求进行语言润色，主动撤稿）。后面经邮件咨询编辑部后，于4.30再次投稿，5.8送外审，6.27审稿意见返回，两个审稿人9个问题，编辑给了7天修改，7.3修回（9个问题回复了9页纸），7.5accept。总体感觉相对不难，但是要注意细节，例如：摘要个格式要严格按照要求来；要有动物伦理证明；如果是单剂量研究要说明理由（正文材料方法中、cover letter都要讲清楚，不然会被退稿）；中药/复方要有传统应用的依据（这里要引用相应的文献支撑）。另外，对于审稿人的刁难，舔就完事了哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jul 05 21:59:09 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162744, encodeId=86b12162e449f, content=请问各位大神，An annotated Table of Contents (Index) must be provided for reviews as required for the journal.是什么意思，要提供什么材料吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Oct 14 11:29:12 CST 2023, time=2023-10-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158170, encodeId=f0ab21581e069, content=偏重的研究方向：药理学;天然药物;药理<br>经验分享：家人们，想问一下投的综述一般要多久送审呀，投了有几天了还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Sun Sep 17 18:24:08 CST 2023, time=2023-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156372, encodeId=dce321563e2be, content=一审：第一个审稿人提了对内容提了7个问题，第二个审稿人给了接收，请问小修回去还需要送外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3008394011, createdName=ms3000000237799877, createdTime=Wed Sep 06 14:15:05 CST 2023, time=2023-09-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2181831, encodeId=490a2181831d7, content=投稿要求“Please download a paper from the journal website and use it as an example to correct the format of your paper.”请问文章格式是什么啊，怎么改啊，急求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff78834013, createdName=ms9000000742155435, createdTime=Mon Jan 15 17:47:34 CST 2024, time=2024-01-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147022, encodeId=0f71214e02205, content=投稿一周了还是submited to journal, 真的很希望送审。我是筛药的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aa96399896, createdName=ms1000000125278461, createdTime=Sat Jul 08 22:12:51 CST 2023, time=2023-07-08, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170852, encodeId=be0d21e085259, content=请问online之后多久能拿到检索证明啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6d5433134, createdName=ms3000001423208311, createdTime=Sat Nov 25 08:16:05 CST 2023, time=2023-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176059, encodeId=c7ae21e6059ed, content=5天了，还是Submitted to Journal，要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Wed Dec 20 10:30:53 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175358, encodeId=411221e5358f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：中药复方<br>经验分享：各位老师，我看投稿要求里说要文章总体介绍的图片，这个大家有上传吗，还是不用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=ms2000000165165359, createdTime=Sun Dec 17 01:54:50 CST 2023, time=2023-12-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2167310, encodeId=0faf216e3103c, content=请问中药抑菌的文章适不适合投呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f48d9034239, createdName=ms1000001299592747, createdTime=Wed Nov 08 00:36:49 CST 2023, time=2023-11-08, status=1, ipAttribution=广西)]
    2024-01-15 ms9000000742155435 来自上海

    投稿要求“Please download a paper from the journal website and use it as an example to correct the format of your paper.”请问文章格式是什么啊，怎么改啊，急求

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2146523, encodeId=4e192146523e2, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：中药复方机制<br>经验分享：4.1第一次投稿，被编辑部退回，理由如下：1. 杂志一般不接受单剂量研究，如果有前期剂量筛选的话要补充依据；2. 补充受试药物的传统应用依据；3. 补充动物伦理证明。起初以为杂志不接受单剂量，转战phytomedicine （编辑建议转投）和frontiers in pharmacology（要求进行语言润色，主动撤稿）。后面经邮件咨询编辑部后，于4.30再次投稿，5.8送外审，6.27审稿意见返回，两个审稿人9个问题，编辑给了7天修改，7.3修回（9个问题回复了9页纸），7.5accept。总体感觉相对不难，但是要注意细节，例如：摘要个格式要严格按照要求来；要有动物伦理证明；如果是单剂量研究要说明理由（正文材料方法中、cover letter都要讲清楚，不然会被退稿）；中药/复方要有传统应用的依据（这里要引用相应的文献支撑）。另外，对于审稿人的刁难，舔就完事了哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jul 05 21:59:09 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162744, encodeId=86b12162e449f, content=请问各位大神，An annotated Table of Contents (Index) must be provided for reviews as required for the journal.是什么意思，要提供什么材料吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Oct 14 11:29:12 CST 2023, time=2023-10-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158170, encodeId=f0ab21581e069, content=偏重的研究方向：药理学;天然药物;药理<br>经验分享：家人们，想问一下投的综述一般要多久送审呀，投了有几天了还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Sun Sep 17 18:24:08 CST 2023, time=2023-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156372, encodeId=dce321563e2be, content=一审：第一个审稿人提了对内容提了7个问题，第二个审稿人给了接收，请问小修回去还需要送外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3008394011, createdName=ms3000000237799877, createdTime=Wed Sep 06 14:15:05 CST 2023, time=2023-09-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2181831, encodeId=490a2181831d7, content=投稿要求“Please download a paper from the journal website and use it as an example to correct the format of your paper.”请问文章格式是什么啊，怎么改啊，急求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff78834013, createdName=ms9000000742155435, createdTime=Mon Jan 15 17:47:34 CST 2024, time=2024-01-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147022, encodeId=0f71214e02205, content=投稿一周了还是submited to journal, 真的很希望送审。我是筛药的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aa96399896, createdName=ms1000000125278461, createdTime=Sat Jul 08 22:12:51 CST 2023, time=2023-07-08, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170852, encodeId=be0d21e085259, content=请问online之后多久能拿到检索证明啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6d5433134, createdName=ms3000001423208311, createdTime=Sat Nov 25 08:16:05 CST 2023, time=2023-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176059, encodeId=c7ae21e6059ed, content=5天了，还是Submitted to Journal，要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Wed Dec 20 10:30:53 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175358, encodeId=411221e5358f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：中药复方<br>经验分享：各位老师，我看投稿要求里说要文章总体介绍的图片，这个大家有上传吗，还是不用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=ms2000000165165359, createdTime=Sun Dec 17 01:54:50 CST 2023, time=2023-12-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2167310, encodeId=0faf216e3103c, content=请问中药抑菌的文章适不适合投呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f48d9034239, createdName=ms1000001299592747, createdTime=Wed Nov 08 00:36:49 CST 2023, time=2023-11-08, status=1, ipAttribution=广西)]
    2023-07-08 ms1000000125278461 来自重庆

    投稿一周了还是submited to journal, 真的很希望送审。我是筛药的文章

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2146523, encodeId=4e192146523e2, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：中药复方机制<br>经验分享：4.1第一次投稿，被编辑部退回，理由如下：1. 杂志一般不接受单剂量研究，如果有前期剂量筛选的话要补充依据；2. 补充受试药物的传统应用依据；3. 补充动物伦理证明。起初以为杂志不接受单剂量，转战phytomedicine （编辑建议转投）和frontiers in pharmacology（要求进行语言润色，主动撤稿）。后面经邮件咨询编辑部后，于4.30再次投稿，5.8送外审，6.27审稿意见返回，两个审稿人9个问题，编辑给了7天修改，7.3修回（9个问题回复了9页纸），7.5accept。总体感觉相对不难，但是要注意细节，例如：摘要个格式要严格按照要求来；要有动物伦理证明；如果是单剂量研究要说明理由（正文材料方法中、cover letter都要讲清楚，不然会被退稿）；中药/复方要有传统应用的依据（这里要引用相应的文献支撑）。另外，对于审稿人的刁难，舔就完事了哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jul 05 21:59:09 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162744, encodeId=86b12162e449f, content=请问各位大神，An annotated Table of Contents (Index) must be provided for reviews as required for the journal.是什么意思，要提供什么材料吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Oct 14 11:29:12 CST 2023, time=2023-10-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158170, encodeId=f0ab21581e069, content=偏重的研究方向：药理学;天然药物;药理<br>经验分享：家人们，想问一下投的综述一般要多久送审呀，投了有几天了还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Sun Sep 17 18:24:08 CST 2023, time=2023-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156372, encodeId=dce321563e2be, content=一审：第一个审稿人提了对内容提了7个问题，第二个审稿人给了接收，请问小修回去还需要送外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3008394011, createdName=ms3000000237799877, createdTime=Wed Sep 06 14:15:05 CST 2023, time=2023-09-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2181831, encodeId=490a2181831d7, content=投稿要求“Please download a paper from the journal website and use it as an example to correct the format of your paper.”请问文章格式是什么啊，怎么改啊，急求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff78834013, createdName=ms9000000742155435, createdTime=Mon Jan 15 17:47:34 CST 2024, time=2024-01-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147022, encodeId=0f71214e02205, content=投稿一周了还是submited to journal, 真的很希望送审。我是筛药的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aa96399896, createdName=ms1000000125278461, createdTime=Sat Jul 08 22:12:51 CST 2023, time=2023-07-08, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170852, encodeId=be0d21e085259, content=请问online之后多久能拿到检索证明啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6d5433134, createdName=ms3000001423208311, createdTime=Sat Nov 25 08:16:05 CST 2023, time=2023-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176059, encodeId=c7ae21e6059ed, content=5天了，还是Submitted to Journal，要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Wed Dec 20 10:30:53 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175358, encodeId=411221e5358f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：中药复方<br>经验分享：各位老师，我看投稿要求里说要文章总体介绍的图片，这个大家有上传吗，还是不用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=ms2000000165165359, createdTime=Sun Dec 17 01:54:50 CST 2023, time=2023-12-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2167310, encodeId=0faf216e3103c, content=请问中药抑菌的文章适不适合投呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f48d9034239, createdName=ms1000001299592747, createdTime=Wed Nov 08 00:36:49 CST 2023, time=2023-11-08, status=1, ipAttribution=广西)]
    2023-11-25 ms3000001423208311 来自浙江省

    请问online之后多久能拿到检索证明啊？

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2146523, encodeId=4e192146523e2, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：中药复方机制<br>经验分享：4.1第一次投稿，被编辑部退回，理由如下：1. 杂志一般不接受单剂量研究，如果有前期剂量筛选的话要补充依据；2. 补充受试药物的传统应用依据；3. 补充动物伦理证明。起初以为杂志不接受单剂量，转战phytomedicine （编辑建议转投）和frontiers in pharmacology（要求进行语言润色，主动撤稿）。后面经邮件咨询编辑部后，于4.30再次投稿，5.8送外审，6.27审稿意见返回，两个审稿人9个问题，编辑给了7天修改，7.3修回（9个问题回复了9页纸），7.5accept。总体感觉相对不难，但是要注意细节，例如：摘要个格式要严格按照要求来；要有动物伦理证明；如果是单剂量研究要说明理由（正文材料方法中、cover letter都要讲清楚，不然会被退稿）；中药/复方要有传统应用的依据（这里要引用相应的文献支撑）。另外，对于审稿人的刁难，舔就完事了哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jul 05 21:59:09 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162744, encodeId=86b12162e449f, content=请问各位大神，An annotated Table of Contents (Index) must be provided for reviews as required for the journal.是什么意思，要提供什么材料吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Oct 14 11:29:12 CST 2023, time=2023-10-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158170, encodeId=f0ab21581e069, content=偏重的研究方向：药理学;天然药物;药理<br>经验分享：家人们，想问一下投的综述一般要多久送审呀，投了有几天了还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Sun Sep 17 18:24:08 CST 2023, time=2023-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156372, encodeId=dce321563e2be, content=一审：第一个审稿人提了对内容提了7个问题，第二个审稿人给了接收，请问小修回去还需要送外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3008394011, createdName=ms3000000237799877, createdTime=Wed Sep 06 14:15:05 CST 2023, time=2023-09-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2181831, encodeId=490a2181831d7, content=投稿要求“Please download a paper from the journal website and use it as an example to correct the format of your paper.”请问文章格式是什么啊，怎么改啊，急求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff78834013, createdName=ms9000000742155435, createdTime=Mon Jan 15 17:47:34 CST 2024, time=2024-01-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147022, encodeId=0f71214e02205, content=投稿一周了还是submited to journal, 真的很希望送审。我是筛药的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aa96399896, createdName=ms1000000125278461, createdTime=Sat Jul 08 22:12:51 CST 2023, time=2023-07-08, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170852, encodeId=be0d21e085259, content=请问online之后多久能拿到检索证明啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6d5433134, createdName=ms3000001423208311, createdTime=Sat Nov 25 08:16:05 CST 2023, time=2023-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176059, encodeId=c7ae21e6059ed, content=5天了，还是Submitted to Journal，要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Wed Dec 20 10:30:53 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175358, encodeId=411221e5358f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：中药复方<br>经验分享：各位老师，我看投稿要求里说要文章总体介绍的图片，这个大家有上传吗，还是不用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=ms2000000165165359, createdTime=Sun Dec 17 01:54:50 CST 2023, time=2023-12-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2167310, encodeId=0faf216e3103c, content=请问中药抑菌的文章适不适合投呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f48d9034239, createdName=ms1000001299592747, createdTime=Wed Nov 08 00:36:49 CST 2023, time=2023-11-08, status=1, ipAttribution=广西)]
    2023-12-20 Spiriting 来自山东省

    5天了，还是Submitted to Journal，要不要催一下

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2146523, encodeId=4e192146523e2, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：中药复方机制<br>经验分享：4.1第一次投稿，被编辑部退回，理由如下：1. 杂志一般不接受单剂量研究，如果有前期剂量筛选的话要补充依据；2. 补充受试药物的传统应用依据；3. 补充动物伦理证明。起初以为杂志不接受单剂量，转战phytomedicine （编辑建议转投）和frontiers in pharmacology（要求进行语言润色，主动撤稿）。后面经邮件咨询编辑部后，于4.30再次投稿，5.8送外审，6.27审稿意见返回，两个审稿人9个问题，编辑给了7天修改，7.3修回（9个问题回复了9页纸），7.5accept。总体感觉相对不难，但是要注意细节，例如：摘要个格式要严格按照要求来；要有动物伦理证明；如果是单剂量研究要说明理由（正文材料方法中、cover letter都要讲清楚，不然会被退稿）；中药/复方要有传统应用的依据（这里要引用相应的文献支撑）。另外，对于审稿人的刁难，舔就完事了哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jul 05 21:59:09 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162744, encodeId=86b12162e449f, content=请问各位大神，An annotated Table of Contents (Index) must be provided for reviews as required for the journal.是什么意思，要提供什么材料吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Oct 14 11:29:12 CST 2023, time=2023-10-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158170, encodeId=f0ab21581e069, content=偏重的研究方向：药理学;天然药物;药理<br>经验分享：家人们，想问一下投的综述一般要多久送审呀，投了有几天了还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Sun Sep 17 18:24:08 CST 2023, time=2023-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156372, encodeId=dce321563e2be, content=一审：第一个审稿人提了对内容提了7个问题，第二个审稿人给了接收，请问小修回去还需要送外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3008394011, createdName=ms3000000237799877, createdTime=Wed Sep 06 14:15:05 CST 2023, time=2023-09-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2181831, encodeId=490a2181831d7, content=投稿要求“Please download a paper from the journal website and use it as an example to correct the format of your paper.”请问文章格式是什么啊，怎么改啊，急求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff78834013, createdName=ms9000000742155435, createdTime=Mon Jan 15 17:47:34 CST 2024, time=2024-01-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147022, encodeId=0f71214e02205, content=投稿一周了还是submited to journal, 真的很希望送审。我是筛药的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aa96399896, createdName=ms1000000125278461, createdTime=Sat Jul 08 22:12:51 CST 2023, time=2023-07-08, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170852, encodeId=be0d21e085259, content=请问online之后多久能拿到检索证明啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6d5433134, createdName=ms3000001423208311, createdTime=Sat Nov 25 08:16:05 CST 2023, time=2023-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176059, encodeId=c7ae21e6059ed, content=5天了，还是Submitted to Journal，要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Wed Dec 20 10:30:53 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175358, encodeId=411221e5358f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：中药复方<br>经验分享：各位老师，我看投稿要求里说要文章总体介绍的图片，这个大家有上传吗，还是不用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=ms2000000165165359, createdTime=Sun Dec 17 01:54:50 CST 2023, time=2023-12-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2167310, encodeId=0faf216e3103c, content=请问中药抑菌的文章适不适合投呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f48d9034239, createdName=ms1000001299592747, createdTime=Wed Nov 08 00:36:49 CST 2023, time=2023-11-08, status=1, ipAttribution=广西)]
    2023-12-17 ms2000000165165359 来自福建省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：中药复方
    经验分享：各位老师，我看投稿要求里说要文章总体介绍的图片，这个大家有上传吗，还是不用

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2146523, encodeId=4e192146523e2, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：中药复方机制<br>经验分享：4.1第一次投稿，被编辑部退回，理由如下：1. 杂志一般不接受单剂量研究，如果有前期剂量筛选的话要补充依据；2. 补充受试药物的传统应用依据；3. 补充动物伦理证明。起初以为杂志不接受单剂量，转战phytomedicine （编辑建议转投）和frontiers in pharmacology（要求进行语言润色，主动撤稿）。后面经邮件咨询编辑部后，于4.30再次投稿，5.8送外审，6.27审稿意见返回，两个审稿人9个问题，编辑给了7天修改，7.3修回（9个问题回复了9页纸），7.5accept。总体感觉相对不难，但是要注意细节，例如：摘要个格式要严格按照要求来；要有动物伦理证明；如果是单剂量研究要说明理由（正文材料方法中、cover letter都要讲清楚，不然会被退稿）；中药/复方要有传统应用的依据（这里要引用相应的文献支撑）。另外，对于审稿人的刁难，舔就完事了哈哈哈！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b5e25499089, createdName=卡球球 zhao, createdTime=Wed Jul 05 21:59:09 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2162744, encodeId=86b12162e449f, content=请问各位大神，An annotated Table of Contents (Index) must be provided for reviews as required for the journal.是什么意思，要提供什么材料吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e545685662, createdName=ms4000001105476217, createdTime=Sat Oct 14 11:29:12 CST 2023, time=2023-10-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158170, encodeId=f0ab21581e069, content=偏重的研究方向：药理学;天然药物;药理<br>经验分享：家人们，想问一下投的综述一般要多久送审呀，投了有几天了还没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13a48217662, createdName=ms6000000645412256, createdTime=Sun Sep 17 18:24:08 CST 2023, time=2023-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156372, encodeId=dce321563e2be, content=一审：第一个审稿人提了对内容提了7个问题，第二个审稿人给了接收，请问小修回去还需要送外审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3008394011, createdName=ms3000000237799877, createdTime=Wed Sep 06 14:15:05 CST 2023, time=2023-09-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2181831, encodeId=490a2181831d7, content=投稿要求“Please download a paper from the journal website and use it as an example to correct the format of your paper.”请问文章格式是什么啊，怎么改啊，急求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff78834013, createdName=ms9000000742155435, createdTime=Mon Jan 15 17:47:34 CST 2024, time=2024-01-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147022, encodeId=0f71214e02205, content=投稿一周了还是submited to journal, 真的很希望送审。我是筛药的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aa96399896, createdName=ms1000000125278461, createdTime=Sat Jul 08 22:12:51 CST 2023, time=2023-07-08, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170852, encodeId=be0d21e085259, content=请问online之后多久能拿到检索证明啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6d5433134, createdName=ms3000001423208311, createdTime=Sat Nov 25 08:16:05 CST 2023, time=2023-11-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176059, encodeId=c7ae21e6059ed, content=5天了，还是Submitted to Journal，要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=aaeb1710704, createdName=Spiriting, createdTime=Wed Dec 20 10:30:53 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175358, encodeId=411221e5358f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：中药复方<br>经验分享：各位老师，我看投稿要求里说要文章总体介绍的图片，这个大家有上传吗，还是不用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c59089313, createdName=ms2000000165165359, createdTime=Sun Dec 17 01:54:50 CST 2023, time=2023-12-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2167310, encodeId=0faf216e3103c, content=请问中药抑菌的文章适不适合投呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f48d9034239, createdName=ms1000001299592747, createdTime=Wed Nov 08 00:36:49 CST 2023, time=2023-11-08, status=1, ipAttribution=广西)]
    2023-11-08 ms1000001299592747 来自广西

    请问中药抑菌的文章适不适合投呢？

    1

    展开1条回复
共500条页码: 2/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分